Drug intelligence / Profile preview

Exobloom

Development stage
Unknown
Lead developer
Dermax
Modality
Peptides, Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Intradermal
01

Overview

Exobloom is an exosome-based biologic skin rejuvenation product developed by Dermax Co., Ltd. for aesthetic and regenerative applications. It is formulated as a regenerative complex containing approximately 5 billion plant-derived exosomes extracted from *Angelica keiskei* leaf cells per dose. The product is a multi-ingredient formulation that includes 11 growth factors, 5 peptides (such as copper tripeptide-1), 45 amino acids, hyaluronic acid, glutathione, and hydrolyzed DNA. Exobloom functions through paracrine signaling, where its exosomal cargo—comprising proteins, miRNA, and cytokines—facilitates intercellular communication to stimulate collagen synthesis, promote tissue repair, and enhance skin elasticity. It is primarily indicated for aesthetic uses, including anti-aging, wound healing, and the improvement of skin texture, firmness, and hyperpigmentation. The product is typically administered via intradermal microinjections (mesotherapy) or topically following microneedling procedures.

Brand names
Exobloom
Other names
Exosome Regenerative ComplexExosome Skin Booster
02

Targets

FGFR3 (Fibroblast growth factor receptor 3)

Beyond the preview

Go deeper on Exobloom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exobloom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call